9009 A meta-analysis of four randomized phase II/III trials adding cetuximab to platinum-based chemotherapy as 1st-line treatment in patients with non-small cell lung cancer (NSCLC)

Authors :: Johan Vansteenkiste
C.A. Butts
Nick Thatcher
Christian Manegold
Frances A. Shepherd
J. Groos
Rafael Rosell
J.L. Pujol
R. Pirker
Thomas J. Lynch
Source :: European Journal of Cancer Supplements. 7:508
Publication Year :: 2009
Publisher :: Elsevier BV, 2009.

Subjects :: Oncology
Cancer Research
Chemotherapy
medicine.medical_specialty
Cetuximab
business.industry
medicine.medical_treatment
chemistry.chemical_element
non-small cell lung cancer (NSCLC)
medicine.disease
chemistry
Meta-analysis
Internal medicine
medicine
In patient
Line (text file)
business
Platinum
medicine.drug

Tools